158 related articles for article (PubMed ID: 29209276)
1. l-Thyroxine in an Oral Liquid or Softgel Formulation Ensures More Normal Serum Levels of Free T4 in Patients with Central Hypothyroidism.
Benvenga S; Capodicasa G; Perelli S
Front Endocrinol (Lausanne); 2017; 8():321. PubMed ID: 29209276
[TBL] [Abstract][Full Text] [Related]
2. Liquid and softgel capsules of l-thyroxine results lower serum thyrotropin levels more than tablet formulations in hypothyroid patients.
Benvenga S
J Clin Transl Endocrinol; 2019 Dec; 18():100204. PubMed ID: 31844631
[TBL] [Abstract][Full Text] [Related]
3. In thyroxine-replaced hypothyroid postmenopausal women under simultaneous calcium supplementation, switch to oral liquid or softgel capsule L-thyroxine ensures lower serum TSH levels and favorable effects on blood pressure, total cholesterolemia and glycemia.
Morini E; Catalano A; Lasco A; Morabito N; Benvenga S
Endocrine; 2019 Sep; 65(3):569-579. PubMed ID: 30919287
[TBL] [Abstract][Full Text] [Related]
4. IN PATIENTS WITH SUBCLINICAL HYPOTHYROIDISM WHILE IN THERAPY WITH TABLET L-T4, THE LIQUID L-T4 FORMULATION IS MORE EFFECTIVE IN RESTORING EUTHYROIDISM.
Fallahi P; Ferrari SM; Antonelli A
Endocr Pract; 2017 Feb; 23(2):170-174. PubMed ID: 27849377
[TBL] [Abstract][Full Text] [Related]
5. Oral L-thyroxine liquid versus tablet in patients with hypothyroidism without malabsorption: a prospective study.
Fallahi P; Ferrari SM; Antonelli A
Endocrine; 2016 Jun; 52(3):597-601. PubMed ID: 26721663
[TBL] [Abstract][Full Text] [Related]
6. Reversible normalisation of serum TSH levels in patients with autoimmune atrophic gastritis who received L-T4 in tablet form after switching to an oral liquid formulation: a case series.
Fallahi P; Ferrari SM; Ruffilli I; Antonelli A
BMC Gastroenterol; 2016 Feb; 16():22. PubMed ID: 26965518
[TBL] [Abstract][Full Text] [Related]
7. Thyroxine softgel capsule in patients with gastric-related T4 malabsorption.
Santaguida MG; Virili C; Del Duca SC; Cellini M; Gatto I; Brusca N; De Vito C; Gargano L; Centanni M
Endocrine; 2015 May; 49(1):51-7. PubMed ID: 25595886
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the adequacy of levothyroxine replacement therapy in patients with central hypothyroidism.
Ferretti E; Persani L; Jaffrain-Rea ML; Giambona S; Tamburrano G; Beck-Peccoz P
J Clin Endocrinol Metab; 1999 Mar; 84(3):924-9. PubMed ID: 10084572
[TBL] [Abstract][Full Text] [Related]
9. Thyroxine Treatment With Softgel Capsule Formulation: Usefulness in Hypothyroid Patients Without Malabsorption.
Trimboli P; Virili C; Centanni M; Giovanella L
Front Endocrinol (Lausanne); 2018; 9():118. PubMed ID: 29619010
[TBL] [Abstract][Full Text] [Related]
10. Treatment of congenital hypothyroidism: comparison between L-thyroxine oral solution and tablet formulations up to 3 years of age.
Vigone MC; Ortolano R; Vincenzi G; Pozzi C; Ratti M; Assirelli V; Vissani S; Cavarzere P; Mussa A; Gastaldi R; Di Mase R; Salerno M; Street ME; Trombatore J; Weber G; Cassio A
Eur J Endocrinol; 2021 Nov; 186(1):45-52. PubMed ID: 34714772
[TBL] [Abstract][Full Text] [Related]
11. TSH Normalization in Bariatric Surgery Patients After the Switch from L-Thyroxine in Tablet to an Oral Liquid Formulation.
Fallahi P; Ferrari SM; Camastra S; Politti U; Ruffilli I; Vita R; Navarra G; Benvenga S; Antonelli A
Obes Surg; 2017 Jan; 27(1):78-82. PubMed ID: 27272506
[TBL] [Abstract][Full Text] [Related]
12. Switching from the tablet to the powder formulation of levothyroxine corrects severe hypothyroidism in a patient with lactose intolerance.
Jojima T; Shinzawa T; Ohira E; Sakurai S; Tomaru T; Iijima T; Kogai T; Usui I; Aso Y
Endocr J; 2022 Aug; 69(8):941-945. PubMed ID: 35249899
[TBL] [Abstract][Full Text] [Related]
13. Thyroid hormone replacement for central hypothyroidism: a randomized controlled trial comparing two doses of thyroxine (T4) with a combination of T4 and triiodothyronine.
Slawik M; Klawitter B; Meiser E; Schories M; Zwermann O; Borm K; Peper M; Lubrich B; Hug MJ; Nauck M; Olschewski M; Beuschlein F; Reincke M
J Clin Endocrinol Metab; 2007 Nov; 92(11):4115-22. PubMed ID: 17711927
[TBL] [Abstract][Full Text] [Related]
14. The Stability of TSH, and Thyroid Hormones, in Patients Treated With Tablet, or Liquid Levo-Thyroxine.
Antonelli A; Elia G; Ragusa F; Paparo SR; Cavallini G; Benvenga S; Ferrari SM; Fallahi P
Front Endocrinol (Lausanne); 2021; 12():633587. PubMed ID: 33790863
[TBL] [Abstract][Full Text] [Related]
15. Shift from Levothyroxine Tablets to Liquid Formulation at Breakfast Improves Quality of Life of Hypothyroid Patients.
Guglielmi R; Grimaldi F; Negro R; Frasoldati A; Misischi I; Graziano F; Cipri C; Guastamacchia E; Triggiani V; Papini E
Endocr Metab Immune Disord Drug Targets; 2018; 18(3):235-240. PubMed ID: 29376496
[TBL] [Abstract][Full Text] [Related]
16. Dynamics of the plasma concentrations of TSH, FT4 and T3 following thyroxine supplementation in congenital hypothyroidism.
Bakker B; Kempers MJ; De Vijlder JJ; Van Tijn DA; Wiedijk BM; Van Bruggen M; Vulsma T
Clin Endocrinol (Oxf); 2002 Oct; 57(4):529-37. PubMed ID: 12354136
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics and Clinical Implications of Two Non-Tablet Oral Formulations of L-Thyroxine in Patients with Hypothyroidism.
Trimboli P; Mouly S
J Clin Med; 2022 Jun; 11(12):. PubMed ID: 35743549
[TBL] [Abstract][Full Text] [Related]
18. Congenital hypothyroidism treatment in infants: a comparative study between liquid and tablet formulations of levothyroxine.
Peroni E; Vigone MC; Mora S; Bassi LA; Pozzi C; Passoni A; Weber G
Horm Res Paediatr; 2014; 81(1):50-4. PubMed ID: 24247169
[TBL] [Abstract][Full Text] [Related]
19. Long term therapy with a new liquid L-thyroxine preparation: bioequivalence with L-T4 tablets.
Carpi A; Toni MG; Maccheroni M; De Gaudio C
Thyroidology; 1992 Dec; 4(3):115-9. PubMed ID: 1285037
[TBL] [Abstract][Full Text] [Related]
20. Switching levothyroxine from the tablet to the oral solution formulation corrects the impaired absorption of levothyroxine induced by proton-pump inhibitors.
Vita R; Saraceno G; Trimarchi F; Benvenga S
J Clin Endocrinol Metab; 2014 Dec; 99(12):4481-6. PubMed ID: 25259910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
